344 related articles for article (PubMed ID: 30132020)
1. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
2. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J
Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566
[TBL] [Abstract][Full Text] [Related]
3. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
[TBL] [Abstract][Full Text] [Related]
5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
6. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
7. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
[TBL] [Abstract][Full Text] [Related]
8. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
[TBL] [Abstract][Full Text] [Related]
11. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
[TBL] [Abstract][Full Text] [Related]
13. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
[TBL] [Abstract][Full Text] [Related]
14. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
15. Qiangxinyin formula protects against isoproterenol-induced cardiac hypertrophy.
Zhou ZY; Ma J; Zhao WR; Shi WT; Zhang J; Hu YY; Yue MY; Zhou WL; Yan H; Tang JY; Wang Y
Phytomedicine; 2024 Jul; 130():155717. PubMed ID: 38810550
[TBL] [Abstract][Full Text] [Related]
16. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes.
Liu BY; Li L; Liu GL; Ding W; Chang WG; Xu T; Ji XY; Zheng XX; Zhang J; Wang JX
Acta Pharmacol Sin; 2021 May; 42(5):701-714. PubMed ID: 32796955
[TBL] [Abstract][Full Text] [Related]
17. Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2/STAT3 signaling pathway.
Liu J; Fu H; Chang F; Wang J; Zhang S; Caudle Y; Zhao J; Yin D
Apoptosis; 2016 May; 21(5):546-57. PubMed ID: 26921179
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol protects against sepsis-induced myocardial dysfunction via direct inhibition of JAK2.
Xie L; Wu Y; Zhou C; Tan Z; Xu H; Chen G; Chen H; Huang G; Fan H; Gao L; Liu B; Zhou Y
Int Immunopharmacol; 2021 Jul; 96():107639. PubMed ID: 34162128
[TBL] [Abstract][Full Text] [Related]
20. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
